about
The continual reassessment method for multiple toxicity grades: a bayesian model selection approach.A phase I/II seamless dose escalation/expansion with adaptive randomization scheme (SEARS).A novel Bayesian seamless phase I/II design.Adaptive dose modification for phase I clinical trials.Bridging continual reassessment method for phase I clinical trials in different ethnic populations.A default method to specify skeletons for Bayesian model averaging continual reassessment method for phase I clinical trials.Sample size determination for mediation analysis of longitudinal data.Comparative review of novel model-assisted designs for phase I clinical trials.Bayesian adaptive linearization method for phase I drug combination trials with dimension reduction
P50
Q33685719-73C2ACF3-D0E5-4780-9E92-F72FA2218EDAQ33685719-9BBC42F5-2D35-4057-825A-5CC3CCE77DC7Q34799578-FC50E595-9C46-4F80-8184-D8ADA6F4E7EAQ34984207-EB6F361C-C97B-4E65-8EB4-B8FB61A714D6Q39878337-16B6C874-7C51-4EED-A464-C40D88A03520Q41519375-B03466A0-F7D8-47F1-8866-AB08E6BA11ADQ47442164-30DBA5CF-82CA-45C2-9CD3-6C43501952A9Q51556326-2A2C5468-C251-4AD3-B761-6E1A0EC0FD1EQ52570874-69AB2986-35ED-44DF-A48B-1FEC1076B26AQ91574871-04C1442C-F654-472A-B23B-0228EFE812C8
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0003-4457-7349
@en
name
Haitao Pan
@ast
Haitao Pan
@en
Haitao Pan
@es
Haitao Pan
@nl
type
label
Haitao Pan
@ast
Haitao Pan
@en
Haitao Pan
@es
Haitao Pan
@nl
prefLabel
Haitao Pan
@ast
Haitao Pan
@en
Haitao Pan
@es
Haitao Pan
@nl
P106
P31
P496
0000-0003-4457-7349